ACRO Members Create New Framework to Advance Decentralized Clinical Trials

The Decentralized Clinical Trials (DCT) Working Party publishes quality-based principles and risk assessment considerations for patient-focused decentralization of clinical trials.

Slide Image
Voice of the Global Clinical Research Industry

The Association of Clinical Research represents companies at the forefront of global clinical research. ACRO members are committed to innovation in clinical development and thought leadership on research policy and COVID-19.

Slide Image
Slider

Responses and Resources for COVID-19

Click here for ACRO’s latest statements on the COVID-19 pandemic.

ACRO News

Read about ACRO’s initiatives, COVID-19 efforts, and more.

Member Innovation Hub

Take a look at how our members are innovating in top focus areas.

US Regulatory Policy

Half of all clinical trials occur in the US. ACRO works with US legislators and regulators to ensure a positive regulatory environment that supports high-quality, safe and ethical clinical research. More »

European Advocacy

ACRO engages with European regulators, connecting its members with critical stakeholders. We support the clinical research industry and provide CRO expertise. More »

CRO Forum

ACRO’s CRO Forum is a formal mechanism to enable clinical research organizations to interact with TransCelerate BioPharma Inc. on a range of issues that impact the industry. More »

Clinical Research Roundtables

In Europe and the US, ACRO gathers government leaders and key stakeholders to inform, educate and promote the unique contributions of clinical research and technology companies. More »

Addressing Industry Pain Points

We help create a predictable, enabling business environment. ACRO’s proactive agenda is focused on policy outcomes that advance specific operational interests of ACRO members. More »

Data Protection & Privacy

ACRO’s Global Data Protection & Privacy Committee advances issues of data privacy, protection and security, and how the industry interprets policies and prepares for upcoming legislation. More »

Subscribe

Get ACRO’s free quarterly newsletter to stay informed about our work and the industry.

News and Comments

COVID-19Lessons Learned

A ‘Holy Grail Moment’ for Clinical Research

November 23, 2020 0 Comments

It was a familiar scenario: A rare disease area of oncology. A new drug candidate. A desire to assess efficacy as safely and quickly as possible, so that if successful, a new therapy could get approved and change lives. But this desire could have been tempered by reality: the trial was going to be challenging and slow…

COVID-19Lessons Learned

Seeing progress through the eyes of patients

November 20, 2020 0 Comments

For the clinical research industry, technological tools improve trial continuity, and generate data that helps power more robust monitoring of safety and quality. They can also be a natural fit for patients. IQVIA also sees study participants liking the direct shipment of medicines, telehealth interactions and at-home visits. In the COVID era and beyond, designing more trials with these kinds of technology-enabled strategies is going to help more people by lowering barriers to participation, and speeding the development of new medicines.

COVID-19Lessons Learned

Are we ready for holistic, virtual access?

November 18, 2020 0 Comments

Diverse technology solutions, like patient telehealth visits, accessing electronic medical records (EMRs) or remote source data verification, can generate vast amounts of data. As the clinical research industry evolves towards its next “new normal” with a higher baseline level of remote monitoring, IQVIA is considering the implications of increasing data access. Are we ready?

COVID-19Lessons Learned

Technology solutions: Weathering a storm, helping envision a future

November 16, 2020 0 Comments

We all had a flurry of unprecedented activity. We were assessing risks to patients and data, and putting in place mitigation strategies to preserve continuity of the studies.” Those strategies involved thousands of amendments to protocols, adapting to sudden changes that impacted patients and sites around the world.

COVID-19Lessons Learned

A new fight sees new tools and new challenges

November 2, 2020

A key pillar in the COVID-19 battle is the rapid development of a safe and effective vaccine. As vaccine R&D shifted into gear and then accelerated throughout 2020, with a rapidly growing number of candidates, platforms and manufacturers, it appeared that a bottleneck in this race could actually be the ability to enroll participants.

COVID-19Lessons Learned

When technology may be the easy part

October 26, 2020

In the 10 weeks following the US’ declaration of a pandemic crisis, hospital ER visits declined for conditions like heart attacks and strokes. Simultaneously, based on clinical trials in the Medidata ecosystem, new subject enrollment declined 30%. But also in that time period, ER visits related to uncontrolled high blood sugar saw less of a decline. Patients continued to seek care. Why?

Join ACRO and Add Your Voice

We help create a global regulatory and business environment
where ACRO members succeed

ACRO Members